Ye X, Shao B, Chu Y
Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, Shanghai.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1994;12(3):223-4.
Effect of trifluoroacetoprimaquine oxalate (M8506) and primaquine (PQ) on blood schizonts of Plasmodium berghei were determined using the method of 4-day suppressive test within extended observation period of 60 d. When mice infected with Plasmodium berghei ANKA strain were treated ig with M8506 or PQ at a same daily dose of 20 mg/kg for 4 d, the cure rates were 100% and 90%, respectively. The two drugs also showed prominent suppressive effects on chloroquine-resistant P. berghei NS line and pyronarine-resistant P. berghei RP line, but the parasitemia still remained positive or all of the mice treated recrudesced, indicating the existence of cross resistance between trifluoroacetoprimaquine and other erythrocytic schizonticides, including chloroquine and pyronaridine.
采用4日抑制试验方法,在60天的延长观察期内,测定了草酸三氟乙酰伯氨喹(M8506)和伯氨喹(PQ)对伯氏疟原虫血液裂殖体的作用。当感染伯氏疟原虫ANKA株的小鼠以20mg/kg的相同日剂量灌胃给予M8506或PQ,连续4天时,治愈率分别为100%和90%。这两种药物对氯喹抗性伯氏疟原虫NS株和派罗宁抗性伯氏疟原虫RP株也显示出显著的抑制作用,但疟原虫血症仍呈阳性,或所有治疗小鼠均复发,表明三氟乙酰伯氨喹与包括氯喹和派罗硝唑在内的其他红细胞内裂殖体杀灭剂之间存在交叉抗性。